Cargando…
Central hypertension is a non‐negligible cardiovascular risk factor
High blood pressure (BP) confers cardiovascular risk. However, the clinical value of central BP remains debatable. In this article, we aim to briefly review the prognosis, diagnosis, and treatment of central hypertension. Central and brachial BPs are closely correlated. In most prospective investiga...
Autores principales: | Cheng, Yi‐Bang, Li, Yan, Cheng, Hao‐Min, Siddique, Saulat, Huynh, Minh Van, Sukonthasarn, Apichard, Chen, Chen‐Huan, Wang, Ji‐Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532928/ https://www.ncbi.nlm.nih.gov/pubmed/36196474 http://dx.doi.org/10.1111/jch.14561 |
Ejemplares similares
-
The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini‐review
por: Huang, Hui‐Chun, et al.
Publicado: (2022) -
Hypertensive emergencies in Asia: A brief review
por: Kotruchin, Praew, et al.
Publicado: (2022) -
The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020) -
Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network
por: Chia, Yook‐Chin, et al.
Publicado: (2021) -
The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
por: Kario, Kazuomi, et al.
Publicado: (2022)